AAAAAA

   
Results: 1-9 |
Results: 9
PHARMACOECONOMIC ASPECTS OF VENLAFAXINE
Authors: ISKEDJIAN M EINARSON TR FASSOS FF
Citation: M. Iskedjian et al., PHARMACOECONOMIC ASPECTS OF VENLAFAXINE, Reviews in contemporary pharmacotherapy, 9(5), 1998, pp. 345-353
ASSESSMENT OF THE EFFECT OF THE ORAL IRON CHELATOR DEFERIPRONE ON ASYMPTOMATIC PLASMODIUM-FALCIPARUM PARASITEMIA IN HUMANS
Authors: THUMA PE OLIVIERI NF MABEZA GF BIEMBA G PARRY D ZULU S FASSOS FF MCCLELLAND RA KOREN G BRITTENHAM GM GORDEUK VR
Citation: Pe. Thuma et al., ASSESSMENT OF THE EFFECT OF THE ORAL IRON CHELATOR DEFERIPRONE ON ASYMPTOMATIC PLASMODIUM-FALCIPARUM PARASITEMIA IN HUMANS, The American journal of tropical medicine and hygiene, 58(3), 1998, pp. 358-364
THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORAL IRON CHELATOR DEFERIPRONE (L1) IN RELATION TO HEMOGLOBIN LEVELS
Authors: FASSOS FF KLEIN J FERNANDES D MATSUI D OLIVIERI NF KOREN G
Citation: Ff. Fassos et al., THE PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORAL IRON CHELATOR DEFERIPRONE (L1) IN RELATION TO HEMOGLOBIN LEVELS, International journal of clinical pharmacology and therapeutics, 34(7), 1996, pp. 288-292
WITHDRAWAL-LIKE EFFECTS OF PENTYLENETETRAZOL AND VALPROATE IN THE NAIVE ORGANISM - A MODEL OF MOTIVATION PRODUCED BY OPIATE WITHDRAWAL
Authors: MUCHA RF FASSOS FF PERL FM
Citation: Rf. Mucha et al., WITHDRAWAL-LIKE EFFECTS OF PENTYLENETETRAZOL AND VALPROATE IN THE NAIVE ORGANISM - A MODEL OF MOTIVATION PRODUCED BY OPIATE WITHDRAWAL, Drug and alcohol dependence, 39(1), 1995, pp. 1-6
QUALITY OF NONSTRUCTURED AND STRUCTURED ABSTRACTS OF ORIGINAL RESEARCH ARTICLES IN THE BRITISH-MEDICAL-JOURNAL, THE CANADIAN-MEDICAL-ASSOCIATION-JOURNAL AND THE JOURNAL-OF-THE-AMERICAN-MEDICAL-ASSOCIATION
Authors: TADDIO A PAIN T FASSOS FF BOON H ILERSICH AL EINARSON TR
Citation: A. Taddio et al., QUALITY OF NONSTRUCTURED AND STRUCTURED ABSTRACTS OF ORIGINAL RESEARCH ARTICLES IN THE BRITISH-MEDICAL-JOURNAL, THE CANADIAN-MEDICAL-ASSOCIATION-JOURNAL AND THE JOURNAL-OF-THE-AMERICAN-MEDICAL-ASSOCIATION, CMAJ. Canadian Medical Association journal, 150(10), 1994, pp. 1611-1615
URINARY IRON EXCRETION DEPENDS ON THE MODE OF ADMINISTRATION OF THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE IN PATIENTS WITH HOMOZYGOUS BETA-THALASSEMIA
Authors: FASSOS FF KLEIN J FERNANDES D MATSUI D OLIVIERI NF KOREN G
Citation: Ff. Fassos et al., URINARY IRON EXCRETION DEPENDS ON THE MODE OF ADMINISTRATION OF THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE IN PATIENTS WITH HOMOZYGOUS BETA-THALASSEMIA, Clinical pharmacology and therapeutics, 55(1), 1994, pp. 70-75
ASSESSMENT OF THE RELATIVE QUALITY-OF-LIFE IN PATIENTS RECEIVING SUBCUTANEOUS DEFEROXAMINE AND THE ORALLY-ACTIVE IRON-CHELATING AGENT L1
Authors: BASRAN RK FASSOS FF SHAW D OLIVIERI NF
Citation: Rk. Basran et al., ASSESSMENT OF THE RELATIVE QUALITY-OF-LIFE IN PATIENTS RECEIVING SUBCUTANEOUS DEFEROXAMINE AND THE ORALLY-ACTIVE IRON-CHELATING AGENT L1, Blood, 84(10), 1994, pp. 10000261-10000261
IRON-BALANCE AND DOSE-RESPONSE STUDIES OF THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) IN IRON-LOADED PATIENTS WITH SICKLE-CELL DISEASE
Authors: COLLINS AF FASSOS FF STOBIE S LEWIS N SHAW D FRY M TEMPLETON DM MCCLELLAND RA KOREN G OLIVIERI NF
Citation: Af. Collins et al., IRON-BALANCE AND DOSE-RESPONSE STUDIES OF THE ORAL IRON CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE (L1) IN IRON-LOADED PATIENTS WITH SICKLE-CELL DISEASE, Blood, 83(8), 1994, pp. 2329-2333
ANALYSIS OF THE COST OF TREATMENT OF TRANSFUSION-DEPENDENT HOMOZYGOUSBETA-THALASSEMIA (HBT) - COMPARISON OF 2 CHELATING REGIMENS
Authors: FASSOS FF LEE F EINARSON TR TYLER BJ MURACA M KOREN G OLIVIERI NF
Citation: Ff. Fassos et al., ANALYSIS OF THE COST OF TREATMENT OF TRANSFUSION-DEPENDENT HOMOZYGOUSBETA-THALASSEMIA (HBT) - COMPARISON OF 2 CHELATING REGIMENS, Blood, 82(10), 1993, pp. 10000470-10000470
Risultati: 1-9 |